The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksValiRx Share News (VAL)

Share Price Information for ValiRx (VAL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.25
Bid: 3.20
Ask: 3.30
Change: 0.00 (0.00%)
Spread: 0.10 (3.125%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 3.25
VAL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Tuesday broker round-up UPDATE

Tue, 10th Jun 2014 09:45

ASOS: Goldman Sachs reduces target price from 6250p to 5750p, while upgrading to strong buy.Avon Rubber: Investec lowers target price from 690p to 680p and downgrades from buy to add.BAE Systems: Investec downgrades from add to hold with a target price of 430p.BG Group: Exane downgrades to neutral with its target price at 1350p.Booker Group: Goldman Sachs lowers target price from 214p to 200p downgrading from strong buy to buy.Cobham: Investec moves target price from 300p to 310p and maintains a reduce rating.easyJet: Liberum Capital cuts target price from 1700p to 1650p and reiterates a hold recommendation.Fenner: Jefferies reduces target price from 490p to 410p and maintains a buy recommendation.First Group: Deutsche Bank shifts target price from 125p to 130p and keeps a hold recommendation.First Quantum Minerals: JP Morgan increases target price from 1100p to 1470p upgrading to overweight.Fuller, Smith and Turner: Numis ups target price from 1050p to 1100p keeping an add rating.Getech: WH Ireland places both its target price (prev.: 92p) and its buy recommendation under review.GKN: Investec lowers target price from 435p to 420p and stays with its add rating.Go-Ahead Group: Deutsche Bank increases target price from 2100p to 2270p and retains a hold recommendation.Gooch & Housego: N+1 Singer moves target price from 695p to 710p upgrading to buy. FinnCap raises target price from 680p to 750p and upgrades from hold to buy. Investec cuts target price from 790p to 740p retaining a buy recommendation.Just Retirement: Espirito Santo cuts target price from 295p to 237p, while leaving its buy recommendation unchanged.Meggitt: Investec moves target price from 560p to 550p and retains its buy recommendation.Oxford Instruments: Investec places both its target price (prev.: 1500p) and its add recommendation under review.Phoenix IT: Numis cuts target price from 130p to 95p maintaining a hold recommendation. Investec lowers target price from 138p to 120p and reiterates its hold recommendation.QinetiQ: Investec downgrades from buy to add with a target price of 225p.Rolls-Royce Group: Investec raises target price from 1160p to 1225p and keeps a buy recommendation.Safestay: Westhouse Securities initiates with a target price of 78p and a buy recommendation.Sepura: Investec ups target price from 160p to 200p and maintains a buy recommendation.Shire Pharmaceuticals: Deutsche Bank raises target price from 3920p to 4350p and maintains a buy recommendation.Sports Direct: Goldman Sachs downgrades from strong buy to buy with a target price of 1100p.Ted Baker: Oriel Securities downgrades from buy to add with a target price of 2200p.Ultra Electronics: Investec raises target price from 1930p to 2100p upgrading from hold to buy.WANdisco: UBS cuts target price from 1535p to 1500p, while leaving its buy recommendation remains unchanged.
More News
21 Mar 2024 11:22

ValiRx inks evaluation deal with Imperial College London for research

(Alliance News) - ValiRx PLC on Thursday said that it has signed an evaluation deal with Imperial College London to look at research on novel therapeutic candidates for cancer treatment.

Read more
19 Mar 2024 19:47

EARNINGS AND TRADING: Ten Lifestyle sees profit up but sales flat

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
13 Feb 2024 14:45

ValiRx says requisition notice from shareholder group is invalid

(Alliance News) - ValiRx PLC on Tuesday said a requisition notice, which it received earlier in February, has been confirmed as invalid following legal advice.

Read more
12 Feb 2024 12:59

ValiRx inks deal with Dundee Drug Discovery Unit

(Sharecast News) - ValiRx announced the signing of a significant agreement with the University of Dundee and its Drug Discovery Unit (DDU) on Monday.

Read more
12 Feb 2024 11:42

IN BRIEF: ValiRx signs research sharing deal with Dundee University

ValiRx PLC - Nuneaton, England-based life sciences company focused on early-stage cancer therapeutics - Signs agreement with Dundee University's drug discovery unit to access research concerning novel therapeutic candidates. The agreement will be active for a period of five years, in which ValiRx may review research projects from the unit in areas aligned with the company's focus on cancer therapeutics.

Read more
9 Feb 2024 20:24

TRADING UPDATES: ValiRx receives shareholder request for board change

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News:

Read more
28 Dec 2023 15:56

UK shareholder meetings calendar - next 7 days

Friday 29 December 
Apollon Formularies PLCAGM
Eco Atlantic Oil & Gas LtdAGM
Genedrive PLCAGM
Goldplat PLCAGM
Lansdowne Oil & Gas PLCGM re capital raise
Marula Mining PLCAGM
Microsaic Systems PLCGM re fundraise
Online Blockchain PLCAGM
Secure Property Development & Investment PLCAGM
SkinBioTherapeutics PLCAGM
Tetragon Financial Group LtdAGM
Woodbois LtdAGM
Zambeef Products PLCAGM
Monday 1 January 
no events scheduled 
Tuesday 2 January 
no events scheduled 
Wednesday 3 January 
Jubilee Metals Group PLCGM re equity raise
Thursday 4 January 
Rotala PLCGM re management buyout
Tintra PLCGM re cancellation, re-registering as private company
ValiRx PLCGM re operational review
  
Copyright 2023 Alliance News Ltd. All Rights Reserved. 

Read more
19 Dec 2023 20:46

IN BRIEF: ValiRx raises GBP192,200, part of wider GBP1.8 million raise

ValiRx PLC - life science company based near Birmingham, England, which is focused on early-stage cancer therapeutics and women's health - Says 3.2 million new shares have been subscribed for at 6 pence per share via a retail offer, raising GBP192,244. Also issues 499,998 new shares via a subscription. In total, raises GBP1.8 million via placing, subscription and retail offer of 30.0 million new shares.

Read more
13 Dec 2023 21:14

TRADING UPDATES: Good Energy says ZapMap expands into mainland Europe

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

Read more
5 Dec 2023 15:08

ValiRx enters option deal with Ambrose Healthcare

(Sharecast News) - Cancer therapeutics-focussed life science company ValiRx announced on Tuesday that its subsidiary ValiSeek has entered into an exclusive option agreement with Ambrose Healthcare, a private UK-based pharmaceutical company.

Read more
5 Dec 2023 11:17

ValiRx says ValiSeek inks deal to licence VAL401 drug with Ambrose

(Alliance News) - ValiRx PLC on Tuesday said that ValiSeek Ltd it has entered a deal to licence VAL401 with Ambrose Healthcare Ltd, a private UK specialist pharmaceutical company.

Read more
5 Dec 2023 10:59

AIM WINNERS & LOSERS: tinyBuild warns on revenue; ValiRx rises

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Tuesday.

Read more
10 Nov 2023 11:49

ValiRx signs deal to evaluate StingRay Bio drug candidates

(Alliance News) - ValiRx PLC on Friday said it has signed a deal with StingRay Bio Ltd to investigate a series of drug candidates.

Read more
10 Nov 2023 10:32

ValiRx enters partnership with StingRay Bio

(Sharecast News) - Life science company ValiRx announced a new partnership with StingRay Bio on Friday, aiming to explore a promising lead series of drug candidates designed for oncology applications.

Read more
6 Oct 2023 11:35

ValiRx sees no reason for shares jump; notes TheoremRx mulls merger

(Alliance News) - ValiRx PLC on Friday said it had no unpublished information that was sensitive to its share price, as it rose significantly.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.